Darrell Michael Riley

Mr. Darrell M.
Riley is a Portfolio Strategist at T.
Rowe Price Associates, Inc. He is a vice president of T.
Rowe Price Group, Inc., and a member of the Multi-Asset Division, the team responsible for managing the firm's multi-asset investment strategies.
Prior to joining the Multi-Asset Division, he held various leadership positions in T.
Rowe Price International Ltd, the organization responsible for the firm's institutional business worldwide.
He started his career at T.
Rowe Price in 1997 as an investment analyst in the Equity Research Group, covering medical technology, hospital supply, and specialty pharmaceutical companies.
Prior to joining the firm, Mr. Riley was an analyst at the investment management firm of Sanford C.
Bernstein & Co., Inc., in New York.
He was previously a director of pharmaceutical and medical device business development for American Cyanamid and a business planning analyst for Eli Lilly & Co. Mr. Riley has a B.S.
in psychobiology, with highest honors, from the University of California at Los Angeles and an M.B.A.
in finance, marketing, and statistics from the University of Chicago.